Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Newcoinson Dec 19, 2017 2:25am

74 Views

Post# 27184481

RE:RE:RE:RE:What do directors know that we don't?

BugattiBoy wrote: WoW, CEO Carman Parente who owns MORE than 10% aka 13 Million+ Shares sold a measly 1.6 Million........ Ooohhhh Noooo. I guess according to your logic he should'nt take home any income this year........ Mongoloid.

MrSilbergleit wrote:

MAZZMEX wrote: Feb 2017......only 100k recently mrs. ilbergleit...mazz..

MrSilbergleit wrote:

Hey mazPUMPING MF! Here is the fresh batch of 1.6M shares ... LOL